XTL Biopharmaceuticals Ltd. (XTLB) Climbed 6.01% or 0.11 To Price $1.89 On Tuesday


XTL Biopharmaceuticals Ltd. (XTLB) climbed 6.01% or 0.11 to $1.89. It is near to 72639 shares traded, which is 242.86% compare to the average total volume 29910. The market cap of XTLB is $9.70 million. The year to date change is -21.04%. The 52 week price range is from $1.55 to $3.94. Price of XTLB have changed -4.81% during last week. It have changed -14.42% over last month, 8.54% over last 3 months, -21.93% over last 6 months and -46.06% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for XTLB is 1.92. It is 1.59% above current price. The 200-day Moving Averages for XTLB is 2.08. It is 10.05% above current price. The 52-week High is 3.94. It is 108.47% from the current price. The 52-week Low is 1.55. It is -17.99% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of XTLB is 1.59 on 2018-06-29. Short % to float is 0.71%. There are some statistics of XTLB. It is has market cap $9.70 million. The share outstanding is 5.14 million. The average volume is 29910. The percent of top 15 Institution holding is 3.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of XTLB is 20.90%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of XTLB is 13.86%.


Tags:

Share this post